Close Menu

Selventa

Selventa and Rosa plan to combine knowledge assets, proprietary data, physiologic model libraries, and expertise in several disease areas with the aim of helping clients make better drug discovery and development decisions.

The two firms' combined modeling and analysis will integrate genomic, transcriptomic, in vitro, animal, and clinical data in a quantitative model.

People In The News

Jeremy Berg is stepping down from NIGMS, Timothy Triche is named to Wafergen's scientific advisory board, and Uwe Neue has died.

The company said it will focus on providing consulting services and software, and help its clients select patient-specific treatments.

Pages

According to New Scientist, GEDmatch changed its terms and conditions over the weekend to opt its users out of law enforcement searches.

The Atlantic looks into time spent pursuing gene leads generated through candidate gene studies.

A twin study uncovers evidence that genes may influence whether someone gets a dog, Martha Stewart reports.

In PNAS this week: Cdx2 cells can help regenerate heart tissue in mice following a heart attack, PIWI-interacting small RNA levels in human cancer, and more.